Thane, Maharashtra is currently experiencing a mixed situation regarding COVID-19. While the city has detected new cases, the civic administration is urging vigilance and assuring residents that the situation is under control.
Recently, ten new COVID-19 cases have been detected in Thane city over the past three days. The Thane Municipal Corporation (TMC) has reported that the affected patients are exhibiting mild symptoms and are currently undergoing treatment at home. The civic body has advised the public not to panic but to adhere to precautionary measures.
In response to these new cases, TMC Commissioner Saurabh Rao has directed the civic health department and hospitals to remain vigilant and alert for the examination and treatment of COVID-19 patients. A high-level review meeting was held on Friday to assess the situation and the readiness of the health system. During this meeting, Dr. Chetna Nitil, the chief medical officer, stated that all patients are stable and recovering at home.
However, amidst these developments, a 21-year-old COVID-19 patient with severe diabetes has died due to "comorbidities" at Chhatrapati Shivaji Maharaj Hospital in Kalwa. The patient had been admitted on Thursday with diabetes-related complications and tested positive for COVID-19 on Friday night. Hospital superintendent Dr. Aniruddha Malgaonkar clarified that the patient's death was linked to his underlying condition.
The Chhatrapati Shivaji Maharaj Hospital has established a dedicated 19-bed ward for COVID-19 patients, equipped with RT-PCR testing facilities. Dr. Chetna Nitil has assured that "a sufficient stock of medicines has been maintained at all health centers, and COVID-19 testing kits are readily available." The civic body has also made arrangements for potential hospital admissions if needed.
In light of these events, the TMC has emphasized that the health machinery is fully prepared and that constant monitoring is underway. The civic body has appealed to the public not to panic. While most of the new cases are mild and being treated at home, the death of the young patient highlights the continued risk, especially for individuals with pre-existing health conditions.